Suspended

Lumbar Interbody Fusion Using The Telamon® Peek™ Versus The Telamon® Hydrosorb™ Fusion Device - A Prospective, Randomized Controlled Trial To Assess Surgical And Clinical Outcomes

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Data Collection

Who is being recruted

Back Pain+13

+ Bone Diseases

+ Hernia

From 18 to 70 Years
+19 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 4
Interventional
Study Start: October 2004
See protocol details

Summary

Principal SponsorMedtronic Spinal and Biologics
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2004

Actual date on which the first participant was enrolled.

Lumbar spinal fusion is commonly performed as a "last resort" in patients with chronic low back pain caused by degenerative changes and instability of the spine. The surgical treatment involves the removal of an intervertebral disc, and subsequently the union of the two adjacent intervertebral bodies, such that a bony connection is formed within time after surgery. Lumbar spinal fusion is being performed with increasing frequency. Many interbody fusion methods have been described. In recent years, several types of fusion cages have been developed. These cages are made of various materials: titanium, stainless steel, carbon fiber or polyethylethylketone (Peek). Fusion cages have been quickly integrated into orthopedic practice. To date, no studies have been conducted that compare the efficacy of nonresorbable and bioresorbable fusion cage devices. In this study the surgical and clinical outcomes are compared of patients with degenerative lumbar spine disorders who undergo lumbar fusion with a nonresorbable versus a bioresorbable fusion cage. Patients with lumbar spinal disorders will be recruited from several European centers and randomly allocated to one of the two intervention groups. In both treatment groups lumbar spinal fusion is performed using a standardized technique. Patients will be evaluated during two years post-operatively. During this follow up period, the clinical outcome and fusion parameters will be assessed.

Official TitleLumbar Interbody Fusion Using The Telamon® Peek™ Versus The Telamon® Hydrosorb™ Fusion Device - A Prospective, Randomized Controlled Trial To Assess Surgical And Clinical Outcomes
Principal SponsorMedtronic Spinal and Biologics
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

102 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 70 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Back PainBone DiseasesHerniaIntervertebral Disc DisplacementMusculoskeletal DiseasesNeurologic ManifestationsPainSigns and SymptomsSpinal DiseasesSpinal StenosisSpondylolisthesisSpondylolysisPathological Conditions, Signs and SymptomsLow Back PainPathological Conditions, AnatomicalSpondylosis

Criteria

9 inclusion criteria required to participate
Both genders, age between 18 and 70 years

Chronic low back pain (> 3 months) with or without leg pain but no signs of motor loss

Based on clinical history, physical examination, and radiographic signs, pain interpreted as emanating from L4-L5 or L5-S1

Symptoms refractory to conservative treatment for at least 3 months

Show More Criteria

10 exclusion criteria prevent from participating
Previous lumbar spinal fusion

All other previous spinal surgery except for successful removal of a herniated disc more than 2 years before entering the study

Symptomatic degenerative disc disorder at more than one lumbar level

Pregnancy or intention to become pregnant during the two year study

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 4 locations

Suspended

BG Unfallklinik Halle, Klinik für Neurochirurgie

Halle, GermanyOpen BG Unfallklinik Halle, Klinik für Neurochirurgie in Google Maps
Suspended

Universität Rostock, Neurochirurgie

Rostock, Germany
Suspended

VU University Medical Center

Amsterdam, Netherlands
Suspended

Leids Universitair Medisch Centrum

Leiden, Netherlands
Suspended4 Study Centers